Clinical Trial Update: Effect of Buccal Fat Pad Derived Stem Cells in Maxillary Sinus Augmentation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating buccal fat pad–derived stem cells for maxillary sinus augmentation in patients with alveolar bone loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Bone Loss

Drugs mentioned

• Buccal Fat Pad Derived Stem Cells (buccal fat pad-derived stem cells)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Alveolar Bone Loss | Phase 1 | Status: UNKNOWN